Back to search
Refractory/Unexplained Chronic Cough
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory/Unexplained Chronic Cough trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory/Unexplained Chronic Cough trials you may qualify forThis is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalation Powder (N…
The goal of this single-cohort clinical trial is to learn whether a smartphone-based Cough Management (CM) program can reduce cough frequency and burden in adul…
Chronic cough is a common troublesome symptom which has a global prevalence of approximately 10%, but with wide variations across continents. Patients with refr…
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).
This study is testing new ways to help people who have chronic cough that has not improved with typical treatments. One approach is called behavioral cough supp…